Publications

View by Year:
 
Harris HW
Clinical outcomes of biologic mesh: where do we stand?
The Surgical clinics of North America, Oct-2013;93(5):1217-25.  Epub 2013 Jul 13.
Harris HW
Biologic mesh for ventral hernia repair: a cautionary tale.
Annals of surgery, Jun-2013;257(6):997-8.
Beard JH, Oresanya LB, Ohene-Yeboah M, Dicker RA, Harris HW
Characterizing the global burden of surgical disease: a method to estimate inguinal hernia epidemiology in Ghana.
World journal of surgery, Mar-2013;37(3):498-503.
Primus FE, Harris HW
A critical review of biologic mesh use in ventral hernia repairs under contaminated conditions.
Hernia : the journal of hernias and abdominal wall surgery, Feb-2013;17(1):21-30.  Epub 2013 Jan 8.
Chuang KI, Leung B, Hsu N, Harris HW
Heparin protects against septic mortality via apoE-antagonism.
American journal of surgery, Sep-2011;202(3):325-35.  Epub 2011 Jul 8.
Spitzer AL, Chuang KI, Victorino GP, Kasravi B, Curran B, Lee D, Harris HW
Chylomicrons combined with endotoxin moderate microvascular permeability.
Innate immunity, Feb-2011;17(3):283-92.  Epub 2010 Apr 27.
Chuang K, Elford EL, Tseng J, Leung B, Harris HW
An expanding role for apolipoprotein E in sepsis and inflammation.
American journal of surgery, Sep-2010;200(3):391-7.  Epub 2010 Apr 21.
Kattan OM, Kasravi FB, Elford EL, Schell MT, Harris HW
Apolipoprotein E-mediated immune regulation in sepsis.
Journal of immunology (Baltimore, Md. : 1950), Jul-15-2008;181(2):1399-408.
Kasravi B, Lee DH, Lee JW, Dada S, Harris HW
Chylomicron-bound LPS selectively inhibits the hepatocellular response to proinflammatory cytokines.
The Journal of surgical research, May-1-2008;146(1):96-103.  Epub 2007 Jul 30.
Barcia AM, Harris HW
Triglyceride-rich lipoproteins as agents of innate immunity.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Nov-15-2005;41 Suppl 7:S498-503.